Experiencing multiple seizures can impact how you live and your day-to-day activities. Certain medicines can help lower the risk of having seizures, which can help you manage your condition. Xcopri ...
Vomiting 2.5 5.9 8.5 Vision blurred 2.5 2.2 8.5 Somnolence 4.7 5.2 8.1 Nasopharyngitis 5.8 6.3 7.6 Fatigue 5.8 7.0 7.2 Coordination abnormal 1.6 4.1 7.2 Tremor 4.1 3.7 6.2 Balance disorder 0.0 1.1 5.1 ...
Rep. John Larson (D-Conn.) said Tuesday that a "complex partial seizure" was what caused him to seize up during a House floor speech the previous day. Why it matters: The 76-year-old's office had ...
The Food and Drug Administration on Wednesday approved Eisai’s epilepsy drug Fyompa as a primary treatment for partial-onset seizures in epileptic patients 12 years or older. Here are three things to ...
Rep. John Larson (D-CT) said he suffered a “complex partial seizure” Monday that caused his speech to stop abruptly on the House floor. Larson, 76, was in the middle of a floor speech when he stopped ...
New Data on Qudexy XR for Partial-Onset Seizures Upsher-Smith announced the results of a year-long, open-label extension study of the safety and efficacy of Qudexy XR (topiramate) extended-release ...
FILE - President Joe Biden talks with Connecticut Gov. Ned Lamont, left, and Rep. John Larson, D-Conn., as he arrives at Bradley International Airport in Windsor Locks, Conn., Friday, June 16, 2023.
Q: My neighbor’s son was just diagnosed with KCNT1 seizures, and they said it was a very rare disorder. Aren’t seizures fairly common in children? A: The brain has many nerve cells that communicate ...
Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai's antiepileptic drug (AED) ...
Forbes contributors publish independent expert analyses and insights. I focus on new drugs and innovations in medical devices. Last week, the FDA approved XCOPRI (cenobamate tablets) to treat ...
The FDA recently approved XCOPRI for adults with partial-onset seizures, its manufacturer announced. “The approval of XCOPRI will provide clinicians with an effective medication for our patients who ...